Syringes - ANVISA Registration 10332200038
Access comprehensive regulatory information for Syringes in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 10332200038 and manufactured by BIOMETRIX LTD. The registration is held by EPTCA MEDICAL DEVICES LTDA. with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including UNION MEDICAL SHENZHEN CO., LTD, SHENZHEN ANTMED CO.,LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10332200038
25351315641200912
01280030000161
Company Information
Dates and Status
Dec 28, 2009
VIGENTE
09/18/2025 19:00:01
Syringes
SERINGA BIOMETRIX PARA INJETORA DE CONTRASTE
BIOMETRIX LTD
10332200044
Nov 28, 2011
Syringes
Seringa para bomba injetora Biometrix
BIOMETRIX LTD
81325990016
Mar 27, 2017
Syringes
Seringa para Angiografia
ANNTOM MEDICA LIMITED
82086770001
Feb 10, 2025
Syringes
Seringa Angiográfica
SHENZHEN ANTMED CO.,LTD.
80102519313
Apr 14, 2025
Syringes
Seringa Angiográfica
BIOTEQUE CORPORATION
80137019015
Jul 29, 2021
Seringas
Seringas Preenchidas OLIFLUSH
Not specified
80273450062
Sep 08, 2025
Seringas
Seringas Preenchidas OLIFLUSH
ZHEJIANG HOPE PHARMA CO., LTD.
80273450062
Sep 08, 2025
Seringas
SERINGA NANUM
NANUM COMPANY CO., LTD.
80886739002
Jul 28, 2025
Seringas
Kit de Seringa Dayset
SHENZHEN ANTMED CO.,LTD.
80102519342
Jun 30, 2025
Seringas
Kit Multi-paciente
SHENZHEN ANTMED CO.,LTD.
80102519337
Jun 09, 2025